Aurora et al. (2022) mutated G6PD in patient-derived melanomas and demonstrated that reduced G6PD function in these melanomas is associated with increased ROS levels, decreased NADPH, depleted glutathione, and reduced spontaneous metastasis compared to control melanomas [15]. This evidence concerns the gene G6PD and melanoma.